KNOLL CAPITAL MANAGEMENT, LLC enters ENTERA BIO LTD. with 5.53M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/20/2024ACC: 0001104659-24-120963
10% Owner
Since Nov 2024
5.53M
Baseline shares
100% direct
5.53M
Direct ownership
1 position
1.55M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares, par value NIS 0.0000769 per share
DirectShares owned5.53M
Total
5.53M direct5.53M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | 5.53M | Direct |
| Total | 5.53M | 5.53M direct |
Derivative Holdings2
Pre-funded warrant
DirectUnderlying security
Ordinary Shares, par value NIS 0.0000769 per share
Underlying shares
347.60K
Shares owned
N/A
Exercise price
0.0
Expiration
—
Exercise window
—
Warrants (right to buy)
DirectUnderlying security
Ordinary Shares, par value NIS 0.0000769 per share
Underlying shares
1.20M
Shares owned
N/A
Exercise price
1
Expiration
—
Exercise window
—
Total
Underlying
1.55M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-funded warrant Direct | Ordinary Shares, par value NIS 0.0000769 per share | 0.0 | — | — | 347.60K | N/A |
| Warrants (right to buy) Direct | Ordinary Shares, par value NIS 0.0000769 per share | 1 | — | — | 1.20M | N/A |
| Total | 1.55M | 0.00 | ||||